Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Max Ritter Pharma was a Swiss chemical-pharmaceutical company originally based in Zurich and later Gland, Switzerland. Founded in the mid-20th century, the company specialized in the distribution, marketing, and sales of pharmaceutical products, notably serving as the Swiss distributor for Guerbet's contrast media starting in 1963. Over its years of operation, it also commercialized dermatological products such as Cremol-P and Basodexan. The company was eventually acquired by Zyma SA, which through subsequent mergers and corporate restructurings became part of Novartis Consumer Health, GSK Consumer Healthcare, and ultimately Haleon.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Max Ritter Pharma.